EFX
Price
$188.41Alerts
Change
+$0.18 (+0.10%)
Updated
Nov 11 closing price
Capitalization
22.27B
90 days until earnings call
Intraday BUY SELL Signals
EXPO
Price
$86.20Alerts
Change
+$0.20 (+0.23%)
Updated
Nov 11 closing price
Capitalization
3.99B
84 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

EFX vs EXPO

EFX vs EXPO Comparison Chart in %
View a ticker or compare two or three
A.I.Advisor
Oct 20, 2026

Which Stock Would AI Choose? Equifax (EFX) vs. Exponent (EXPO) Stock Comparison

Key Takeaways

  • Different business models: Equifax is a global data, analytics, and technology company best known as one of the three major U.S. consumer credit bureaus, while Exponent is a science and engineering consulting firm serving high-stakes technical and regulatory problems.
  • Contrasting earnings momentum: Equifax delivered a strong Q3 earnings beat that lifted shares roughly 12% in a single session, while Exponent raised its full-year 2026 revenue guidance to 9%–10% growth.
  • Divergent year-to-date paths: Equifax has underperformed the broader market for much of 2026 despite the recent rally, whereas Exponent has shown improving near-term momentum after a choppier multi-year stretch.
  • Different risk profiles: Equifax carries exposure to mortgage and consumer-credit cyclicality, while Exponent faces utilization and valuation risks tied to its premium multiple.
  • Relative valuation gap: Exponent trades near a 29x earnings multiple versus a lower forward multiple for Equifax, reflecting distinct investor expectations.

Introduction

Investors evaluating business-services and information-sector names often weigh data-driven scale against specialist consulting expertise. EFX (Equifax Inc.) and EXPO (Exponent, Inc.) sit in different corners of this landscape, yet both attract attention for their relative performance, market positioning, and growth catalysts. This stock comparison is relevant for traders seeking momentum signals and for longer-horizon investors assessing business-model durability, margin profiles, and sector exposure. By examining recent earnings, guidance revisions, and sentiment shifts, readers can better understand how these two companies compare in the current market environment without relying on a single metric or short-term price move.

EFX Overview and Recent Performance

EFX is a global data, analytics, and technology company whose core franchises include workforce solutions, U.S. information solutions, and international credit data. As one of the three dominant U.S. consumer credit bureaus, Equifax generates a substantial portion of revenue from mortgage-related credit reporting, which makes its results sensitive to interest-rate and housing-market cycles.

In recent market activity, Equifax reported third-quarter revenue of approximately $1.69 billion, up 10% year over year, with adjusted earnings per share (EPS) of $2.26 that topped analyst expectations. The stock rallied roughly 12% in a single session as investors focused on resilience in diversified markets, a 15% increase in U.S. mortgage revenue, and strong growth in talent solutions. Sentiment has also been shaped by management's emphasis on artificial intelligence (AI) productivity savings of about $150 million and growing government contracts, which partly offset softer mortgage demand. Even so, the company trimmed its full-year 2026 revenue guidance, and the stock has underperformed the S&P 500 over the course of 2026, reflecting persistent mortgage headwinds and select price-target reductions from analysts.

EXPO Overview and Recent Performance

EXPO is a science and engineering consulting firm that advises clients on complex technical, scientific, and regulatory challenges, including product safety, failure analysis, and emerging fields such as AI safety and distributed energy systems. Its business is capital-light, project-driven, and reputation-sensitive, with revenue tied to client demand for specialized expertise.

In recent weeks, Exponent reported second-quarter revenue of roughly $171.6 million, up 20.9% year over year, while operating profit rose 63.1%. Management raised its full-year 2026 revenue growth outlook to 9%–10% before reimbursements and expanded its share-repurchase authorization, signaling confidence in cash generation. The stock trades near the $69 level and carries a premium earnings multiple of roughly 29x, above the broader professional-services peer average. Analyst coverage skews constructive, with Overweight and Buy ratings alongside a Neutral view, though insider selling activity and questions about consultant utilization and margin sustainability remain key areas of investor focus. The company also maintains a modest quarterly dividend.

Trending AI Robots

For traders who prefer a data-driven, systematic approach to relative performance, Tickeron's Trending AI Robots page offers a curated view of the platform's AI trading bots. Tickeron hosts hundreds of AI Trading Bots that trade thousands of different tickers, but only the most suitable performers for current market conditions earn a place in this featured section. Each bot applies its own trading style, strategy, timeframe, and statistical profile across a distinct set of tickers, giving users a range of approaches to compare. Visitors can review performance statistics and strategy details to identify bots that align with their own analytical preferences. Explore the Trending AI Robots section to see which automated strategies are currently in focus.

Head-to-Head Comparison

Although both EFX and EXPO operate in the broad business-services space, their growth drivers and risk exposures differ sharply. Equifax benefits from recurring, high-margin data revenue, but its fortunes are closely tied to mortgage volumes and consumer-credit cycles, which makes its results more sensitive to interest rates. Exponent, by contrast, generates revenue from expert consulting engagements and is less exposed to credit cycles, yet its premium valuation leaves less room for error if utilization or billing rates soften.

From a momentum standpoint, Equifax has shown recent upside on its earnings beat, while Exponent has posted a steadier recovery following a period of weaker multi-year returns. On valuation, Equifax trades at a lower forward earnings multiple, reflecting market caution around mortgage-driven revenue, whereas Exponent commands a higher multiple supported by its capital-light model and free-cash-flow generation. Sector exposure also differs: Equifax sits at the intersection of financial data and technology, while Exponent is tied to engineering, regulatory, and litigation-driven demand. These trade-offs mean the two stocks appeal to different investor profiles rather than competing directly on the same fundamentals.

Tickeron AI Verdict

Based on observable factors such as trend consistency, catalyst quality, and relative positioning, Tickeron's AI would likely weigh Equifax's stronger near-term earnings momentum and improving cost discipline against Exponent's more stable, capital-light profile and raised guidance. The recent earnings-driven rally and clear AI-productivity narrative give Equifax a more defined catalyst set in the near term, while Exponent's premium valuation and utilization concerns introduce a higher bar for continued outperformance. On balance, the AI framework would probably favor Equifax for its combination of an earnings beat, a clearer margin-expansion story, and a more attractive relative valuation, while acknowledging that mortgage-cycle sensitivity remains the primary risk to that outlook.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

VS
EFX vs. EXPO commentary
Nov 12, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is EFX is a Buy and EXPO is a Hold.

Interact to see
Advertisement
SUMMARIES
A.I.Advisor
a Summary for EFX with price predictions
Nov 11, 2026

EFX's MACD Histogram crosses above signal line

The Moving Average Convergence Divergence (MACD) for EFX turned positive on October 08, 2026. Looking at past instances where EFX's MACD turned positive, the stock continued to rise in 36 of 47 cases over the following month. The odds of a continued upward trend are 77%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on October 12, 2026. You may want to consider a long position or call options on EFX as a result. In 60 of 80 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 75%.

EFX moved above its 50-day moving average on October 20, 2026 date and that indicates a change from a downward trend to an upward trend.

The 10-day moving average for EFX crossed bullishly above the 50-day moving average on October 26, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 9 of 12 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 75%.

Following a +3.26% 3-day Advance, the price is estimated to grow further. Considering data from situations where EFX advanced for three days, in 198 of 327 cases, the price rose further within the following month. The odds of a continued upward trend are 61%.

The Aroon Indicator entered an Uptrend today. In 143 of 224 cases where EFX Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 64%.

Bearish Trend Analysis

The 10-day RSI Indicator for EFX moved out of overbought territory on November 06, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 27 similar instances where the indicator moved out of overbought territory. In 18 of the 27 cases, the stock moved lower in the following days. This puts the odds of a move lower at 67%.

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In 46 of 68 cases where EFX's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are 68%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where EFX declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 70%.

EFX broke above its upper Bollinger Band on October 22, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is 40 (best 1 - 100 worst), indicating steady price growth. EFX’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is 58 (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is 66 (best 1 - 100 worst), pointing to average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Valuation Rating of 80 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (5.085) is normal, around the industry mean (13.131). P/E Ratio (33.087) is within average values for comparable stocks, (49.500). Projected Growth (PEG Ratio) (1.221) is also within normal values, averaging (2.814). Dividend Yield (0.012) settles around the average of (0.026) among similar stocks. P/S Ratio (3.088) is also within normal values, averaging (26.240).

The Tickeron Seasonality Score of 85 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. EFX’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 92, placing this stock worse than average.

A.I.Advisor
a Summary for EXPO with price predictions
Nov 11, 2026

EXPO in +0.87% Uptrend, rising for three consecutive days on November 11, 2026

Moving higher for three straight days is viewed as a bullish sign. Keep an eye on this stock for future growth. Considering data from situations where EXPO advanced for three days, in 165 of 279 cases, the price rose further within the following month. The odds of a continued upward trend are 59%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The 10-day moving average for EXPO crossed bullishly above the 50-day moving average on October 12, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 8 of 14 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 57%.

The Aroon Indicator entered an Uptrend today. In 126 of 222 cases where EXPO Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 57%.

Bearish Trend Analysis

The RSI Indicator has been in the overbought zone for 2 days. Expect a price pull-back in the near future.

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In 39 of 64 cases where EXPO's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are 61%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where EXPO declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 61%.

EXPO broke above its upper Bollinger Band on November 02, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron SMR rating for this company is 31 (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is 34 (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is 36 (best 1 - 100 worst), indicating steady price growth. EXPO’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Seasonality Score of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Valuation Rating of 89 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (13.841) is normal, around the industry mean (15.143). P/E Ratio (37.509) is within average values for comparable stocks, (167.534). Projected Growth (PEG Ratio) (2.730) is also within normal values, averaging (3.522). Dividend Yield (0.015) settles around the average of (0.215) among similar stocks. P/S Ratio (5.402) is also within normal values, averaging (2.886).

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. EXPO’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 78, placing this stock worse than average.

FUNDAMENTALS RATINGS
EFX vs EXPO: Fundamental Ratings
EFX
EXPO
OUTLOOK RATING
1..100
2545
VALUATION
overvalued / fair valued / undervalued
1..100
80
Overvalued
89
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
5831
PRICE GROWTH RATING
1..100
4036
P/E GROWTH RATING
1..100
6634
SEASONALITY SCORE
1..100
8550

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

EFX's Valuation (80) in the Miscellaneous Commercial Services industry is in the same range as EXPO (89) in the Engineering And Construction industry. This means that EFX’s stock grew similarly to EXPO’s over the last 12 months.

EFX's Profit vs Risk Rating (100) in the Miscellaneous Commercial Services industry is in the same range as EXPO (100) in the Engineering And Construction industry. This means that EFX’s stock grew similarly to EXPO’s over the last 12 months.

EXPO's SMR Rating (31) in the Engineering And Construction industry is in the same range as EFX (58) in the Miscellaneous Commercial Services industry. This means that EXPO’s stock grew similarly to EFX’s over the last 12 months.

EXPO's Price Growth Rating (36) in the Engineering And Construction industry is in the same range as EFX (40) in the Miscellaneous Commercial Services industry. This means that EXPO’s stock grew similarly to EFX’s over the last 12 months.

EXPO's P/E Growth Rating (34) in the Engineering And Construction industry is in the same range as EFX (66) in the Miscellaneous Commercial Services industry. This means that EXPO’s stock grew similarly to EFX’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
EFXEXPO
RSI
ODDS (%)
Bearish Trend 1 day ago
67%
Bearish Trend 1 day ago
61%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
68%
Bearish Trend 1 day ago
61%
Momentum
ODDS (%)
Bullish Trend 1 day ago
75%
N/A
MACD
ODDS (%)
Bullish Trend 4 days ago
77%
N/A
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
71%
Bearish Trend 1 day ago
63%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
62%
Bullish Trend 1 day ago
56%
Advances
ODDS (%)
Bullish Trend 8 days ago
61%
Bullish Trend 1 day ago
59%
Declines
ODDS (%)
Bearish Trend 3 days ago
70%
Bearish Trend 7 days ago
61%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
69%
Bearish Trend 1 day ago
59%
Aroon
ODDS (%)
Bullish Trend 1 day ago
64%
Bullish Trend 1 day ago
57%
COMPARISON
Comparison
Nov 12, 2026
Stock price -- (EFX: $188.41 vs. EXPO: $86.20)
Brand notoriety: EFX and EXPO are both not notable
EFX represents the Data Processing Services, while EXPO is part of the Engineering & Construction industry
Current volume relative to the 65-day Moving Average: EFX: 50% vs. EXPO: 41%
Market capitalization -- EFX: $22.27B vs. EXPO: $3.99B
EFX [@Data Processing Services] is valued at $22.27B. EXPO’s [@Engineering & Construction] market capitalization is $3.99B. The market cap for tickers in the [@Data Processing Services] industry ranges from $12.21K to $30.34B. The market cap for tickers in the [@Engineering & Construction] industry ranges from $69 to $2.15T. The average market capitalization across the [@Data Processing Services] industry is $3.14B. The average market capitalization across the [@Engineering & Construction] industry is $6.82B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

EFX’s FA Score shows that 0 FA rating(s) are green while EXPO’s FA Score has 1 green FA rating(s).

  • EFX’s FA Score: 0 green, 5 red.
  • EXPO’s FA Score: 1 green, 4 red.
According to our system of comparison, EXPO is a better buy in the long-term than EFX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

EFX’s TA Score shows that 6 TA indicator(s) are bullish while EXPO’s TA Score has 3 bullish TA indicator(s).

  • EFX’s TA Score: 6 bullish, 4 bearish.
  • EXPO’s TA Score: 3 bullish, 4 bearish.
According to our system of comparison, EFX is a better buy in the short-term than EXPO.

Price Growth

EFX (@Data Processing Services) experienced а -1.98% price change this week, while EXPO (@Engineering & Construction) price change was -1.41% for the same time period.

The average weekly price growth across all stocks in the @Data Processing Services industry was -2.68%. For the same industry, the average monthly price growth was -1.54%, and the average quarterly price growth was +1.48%.

The average weekly price growth across all stocks in the @Engineering & Construction industry was -1.02%. For the same industry, the average monthly price growth was -10.11%, and the average quarterly price growth was -26.19%.

Reported Earning Dates

EFX is expected to report earnings on Feb 10, 2027.

EXPO is expected to report earnings on Feb 04, 2027.

Industries' Descriptions

@Data Processing Services (-2.68% weekly)

The industry involves capturing raw data from various sources, extracting meaningful information from it and presenting it in a more accessible digital format. Many people would agree that data is the new gold, which makes data processing services all the more relevant for businesses’ strategic decisions. PayPal Holdings Inc., Fidelity National Information Services, Inc. and Automatic Data Processing, Inc. some of the big players in his burgeoning industry.

@Engineering & Construction (-1.02% weekly)

Engineering & Construction includes companies that engage in non-residential construction and contract services, including ventilation, heating and air conditioning (HVAC) services. The level/value of construction & engineering activity is one of the potentially relevant indicators of the health of businesses, and hence of the overall economy. Some of the large-cap U.S. companies in this industry include Jacobs Engineering Group Inc,, AECOM and Quanta Services, Inc.

View a ticker or compare two or three
Interact to see
Advertisement

EFX and

Correlation & Price change

A.I.dvisor indicates that over the last year, EFX has been loosely correlated with TRU. These tickers have moved in lockstep 65% of the time. This A.I.-generated data suggests there is some statistical probability that if EFX jumps, then TRU could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To EFX
1D Price
Change %
EFX100%
+0.10%
TRU - EFX
65%
Loosely correlated
-0.06%
EXPO - EFX
56%
Loosely correlated
+0.23%
VRSK - EFX
53%
Loosely correlated
+0.96%
MSA - EFX
49%
Loosely correlated
+0.57%
ARLO - EFX
48%
Loosely correlated
-0.24%
More

EXPO and

Correlation & Price change

A.I.dvisor indicates that over the last year, EXPO has been loosely correlated with CTAS. These tickers have moved in lockstep 62% of the time. This A.I.-generated data suggests there is some statistical probability that if EXPO jumps, then CTAS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To EXPO
1D Price
Change %
EXPO100%
+0.23%
CTAS - EXPO
62%
Loosely correlated
+0.88%
ALLE - EXPO
61%
Loosely correlated
+0.84%
CBZ - EXPO
59%
Loosely correlated
N/A
DLB - EXPO
58%
Loosely correlated
-0.02%
TRI - EXPO
55%
Loosely correlated
+0.39%
More
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
BMRN58.331.20
+2.10%
BioMarin Pharmaceutical
FIVN28.070.32
+1.15%
Five9
RBB26.00-0.09
-0.34%
RBB Bancorp
ASPS5.40-0.10
-1.82%
Altisource Portfolio Solutions S.A.
NIKI1.57-0.04
-2.48%
Niki BioSolutions Inc